Wiley-Blackwell
Pheochromocytoma: First International Symposium, Volume 1073
Pheochromocytoma: First International Symposium, Volume 1073
Between 30 and 35% of the tumors have a hereditary basis. Development of malignancy is highly variable -- from less than 5% to more than 50% depending on the mutation; there is currently no effective cure.
This volume encompasses a number of themes in several sections: genetics and clinical decision-making; genetics, molecular pathways of tumorigenesis, and divergent phenotypes; kaleidoscopic presentations and a minefield for differential diagnosis of pheochromocytoma; biochemical diagnosis: can we reach consensus?; tumor localization and the evolving importance of functional imaging; and new molecular markers and targets for diagnosis and treatment of malignant pheochromcytoma.
NOTE: Annals volumes are available for sale as individual books or as a journal. For information on institutional journal subscriptions, please visit www.blackwellpublishing.com/nyas.
ACADEMY MEMBERS Please contact the New York Academy of Sciences directly to place your order (www.nyas.org). Members of the New York Academy of Science receive full-text access to the Annals online and discounts on print volumes. Please visit http: //www.nyas.org/MemberCenter/Join.aspx for more information about becoming a member
| Author: Karel Pacak |
| Publisher: Wiley-Blackwell |
| Publication Date: Aug 21, 2006 |
| Number of Pages: 328 pages |
| Binding: Paperback or Softback |
| ISBN-10: 1573315974 |
| ISBN-13: 9781573315975 |